QRG Capital Management Inc. Decreases Stake in Axon Enterprise, Inc. (NASDAQ:AXON)

QRG Capital Management Inc. lessened its holdings in Axon Enterprise, Inc. (NASDAQ:AXON) by 10.7% during the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 2,246 shares of the biotechnology company’s stock after selling 269 shares during the period. QRG Capital Management Inc.’s holdings in Axon Enterprise were worth $1,335,000 at the end of the most recent reporting period.

Several other institutional investors also recently modified their holdings of the business. New Wave Wealth Advisors LLC purchased a new stake in Axon Enterprise during the fourth quarter worth about $40,000. Y.D. More Investments Ltd bought a new position in shares of Axon Enterprise during the 4th quarter valued at approximately $45,000. Prestige Wealth Management Group LLC increased its stake in shares of Axon Enterprise by 115.8% during the 3rd quarter. Prestige Wealth Management Group LLC now owns 82 shares of the biotechnology company’s stock worth $33,000 after purchasing an additional 44 shares during the last quarter. Stonebridge Financial Group LLC bought a new stake in shares of Axon Enterprise in the 4th quarter worth approximately $53,000. Finally, GPS Wealth Strategies Group LLC lifted its stake in Axon Enterprise by 74.1% in the fourth quarter. GPS Wealth Strategies Group LLC now owns 94 shares of the biotechnology company’s stock valued at $56,000 after purchasing an additional 40 shares during the last quarter. 79.08% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

A number of analysts have issued reports on the company. Barclays set a $726.00 target price on Axon Enterprise and gave the stock an “overweight” rating in a research report on Thursday. Needham & Company LLC reissued a “buy” rating and issued a $600.00 price objective on shares of Axon Enterprise in a report on Wednesday, February 26th. The Goldman Sachs Group upped their price objective on shares of Axon Enterprise from $500.00 to $700.00 and gave the company a “buy” rating in a report on Monday, January 27th. Northcoast Research downgraded shares of Axon Enterprise from a “buy” rating to a “neutral” rating in a research note on Wednesday, February 19th. Finally, JMP Securities restated an “outperform” rating on shares of Axon Enterprise in a research note on Tuesday, February 4th. Three research analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $587.38.

Axon Enterprise Stock Performance

NASDAQ AXON opened at $525.75 on Tuesday. The company’s 50 day simple moving average is $607.58 and its two-hundred day simple moving average is $526.43. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.96 and a quick ratio of 2.63. Axon Enterprise, Inc. has a 1 year low of $273.52 and a 1 year high of $715.99. The stock has a market capitalization of $40.09 billion, a PE ratio of 135.85, a P/E/G ratio of 5.17 and a beta of 1.05.

Insider Buying and Selling

In other Axon Enterprise news, Director Michael Garnreiter sold 1,000 shares of the business’s stock in a transaction that occurred on Monday, December 16th. The shares were sold at an average price of $639.69, for a total value of $639,690.00. Following the completion of the transaction, the director now owns 24,259 shares of the company’s stock, valued at $15,518,239.71. The trade was a 3.96 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Caitlin Elizabeth Kalinowski sold 450 shares of the firm’s stock in a transaction on Thursday, January 2nd. The shares were sold at an average price of $604.07, for a total transaction of $271,831.50. Following the sale, the director now owns 6,929 shares in the company, valued at approximately $4,185,601.03. This trade represents a 6.10 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 6,407 shares of company stock worth $4,122,925. Corporate insiders own 6.10% of the company’s stock.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.